Abstract
Isoprenaline, acting at beta-adrenoceptors (ARs), enhances memory formation in single trial discriminated avoidance learning in day-old chicks by mechanisms involving alterations in glucose and glycogen metabolism. Earlier studies of memory consolidation in chicks indicated that beta3-ARs enhanced memory by increasing glucose uptake, whereas beta2-ARs enhance memory by increasing glycogenolysis. This study examines the ability of beta-ARs to increase glucose uptake in chick forebrain astrocytes. The beta-AR agonist isoprenaline increased glucose uptake in a concentration-dependent manner, as did insulin. Glucose uptake was increased by the beta2-AR agonist zinterol and the beta3-AR agonist CL316243, but not by the beta1-AR agonist RO363. In chick astrocytes, reverse transcription-polymerase chain reaction studies showed that beta1-, beta2-, and beta3-AR mRNA were present, whereas radioligand-binding studies showed the presence of only beta2- and beta3-ARs. beta-AR or insulin-mediated glucose uptake was inhibited by phosphatidylinositol-3 kinase and protein kinase C inhibitors, suggesting a possible interaction between the beta-AR and insulin pathways. However beta2- and beta3-ARs increase glucose uptake by two different mechanisms: beta2-ARs via a Gs-cAMP-protein kinase A-dependent pathway, while beta3-ARs via interactions with Gi. These results indicate that activation of beta2- and beta3-ARs causes glucose uptake in chick astrocytes by distinct mechanisms, which may be relevant for memory enhancement.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-2 Receptor Agonists
-
Adrenergic beta-3 Receptor Agonists
-
Adrenergic beta-Agonists / pharmacology
-
Animals
-
Astrocytes / drug effects
-
Astrocytes / metabolism*
-
Brain / cytology
-
Brain / metabolism*
-
Cells, Cultured
-
Chick Embryo
-
Dioxoles / pharmacology
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Ethanolamines / pharmacology
-
GTP-Binding Protein alpha Subunits, Gi-Go / drug effects
-
GTP-Binding Protein alpha Subunits, Gi-Go / metabolism
-
GTP-Binding Protein alpha Subunits, Gs / drug effects
-
GTP-Binding Protein alpha Subunits, Gs / metabolism
-
Glucose / metabolism*
-
Glucose / pharmacokinetics
-
Insulin / metabolism
-
Insulin / pharmacology
-
Isoproterenol / pharmacology
-
Memory / drug effects
-
Memory / physiology*
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / metabolism
-
RNA, Messenger / drug effects
-
RNA, Messenger / metabolism
-
Receptors, Adrenergic, beta-2 / genetics
-
Receptors, Adrenergic, beta-2 / metabolism*
-
Receptors, Adrenergic, beta-3 / genetics
-
Receptors, Adrenergic, beta-3 / metabolism*
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
Substances
-
Adrenergic beta-2 Receptor Agonists
-
Adrenergic beta-3 Receptor Agonists
-
Adrenergic beta-Agonists
-
Dioxoles
-
Enzyme Inhibitors
-
Ethanolamines
-
Insulin
-
Phosphoinositide-3 Kinase Inhibitors
-
RNA, Messenger
-
Receptors, Adrenergic, beta-2
-
Receptors, Adrenergic, beta-3
-
disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate
-
zinterol
-
Protein Kinase C
-
GTP-Binding Protein alpha Subunits, Gi-Go
-
GTP-Binding Protein alpha Subunits, Gs
-
Glucose
-
Isoproterenol